Notice2025-07281
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 28, 2025
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled substances.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 80 (Monday, April 28, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 80 (Monday, April 28, 2025)]
[Notices]
[Page 17626]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-07281]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1512]
Bulk Manufacturer of Controlled Substances Application: Pharmaron
Manufacturing Services (US), LLC; Correction
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) published a document
in the Federal Register on March 26, 2025, concerning a notice of
application for bulk manufacturer of Controlled Substances. As that
document indicated the registrant's incorrect plans for the listed
controlled substances.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register (FR) of March 26, 2025, in FR Doc. 2025-
05055 (90 FR 13782), on page 13782, Column 3, under Supplementary
Information correction to the paragraph underneath controlled substance
table should read as follows: The company plans to bulk manufacture
Noroxymorphone (9668) as an intermediate product to be sold to its
customers under the Contract Manufacture Organization (CMO) which the
material will be shipped to, and converted to a non-controlled
substance. Oxymorphone (9652) will be used as a starting material to be
converted to Noroxymorphone. No other activities for these drug codes
are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-07281 Filed 4-25-25; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on April 28, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.